Clark Pan

Clark Pan is an accomplished leader in the biotherapeutics and genetic medicine field, currently serving as Vice President at AbbVie since April 2023. Prior to this role, Clark held several key positions at Pfizer, where responsibilities included oversight of gene therapy and editing platforms across multiple therapeutic areas within rare diseases. Earlier experience includes leadership positions at Takeda, Shire, Genzyme/Sanofi, Bayer, and Genentech, involving significant contributions to drug development and protein engineering. Clark earned a PhD in Molecular Biology from UCLA and holds dual degrees in Genetics and Chemistry from UC Davis.